THROMBOTIC MICROANGIOPATHY
Clinical trials for THROMBOTIC MICROANGIOPATHY explained in plain language.
Never miss a new study
Get alerted when new THROMBOTIC MICROANGIOPATHY trials appear
Sign up with your email to follow new studies for THROMBOTIC MICROANGIOPATHY, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New hope for stem cell transplant patients with dangerous blood clotting disorder
Disease control CompletedThis study tested a drug called ravulizumab in people aged 12 and older who developed a serious blood clotting condition (thrombotic microangiopathy) after a stem cell transplant. The goal was to see if the drug could prevent death or worsening of the condition over 26 weeks. Par…
Matched conditions: THROMBOTIC MICROANGIOPATHY
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
New drug shows promise for rare post-transplant complication in kids
Disease control CompletedThis study tested a drug called ravulizumab in 41 children who developed a serious blood clotting problem (TMA) after a stem cell transplant. The goal was to see if the drug could help control the condition and improve blood counts and kidney function. The treatment lasted 26 wee…
Matched conditions: THROMBOTIC MICROANGIOPATHY
Phase: PHASE3 • Sponsor: Alexion Pharmaceuticals, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:10 UTC